Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Trends
There Is A Lot In Store For Big Pharma.
The Big Pharma is expecting higher gains in 2021, and surprisingly, this is not because of COVID-19. Focus on the anti inflammatory and diabetes drugs has kept the spirits high with new clinical data...
Sputnik V working to take AstraZeneca vaccine efficacy to over 90 per cent.
With the DCGI approving Serum Institute of India's Covishield vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving way for their roll-out..